This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Chunghui Huang in Cancer Treatment
Introduction
Chunghui Huang is an accomplished inventor based in Arlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific genetic mutations associated with various diseases.
Latest Patents
Chunghui Huang holds a patent for PRMT5 inhibitors. The present invention provides a compound of Formula (I) and the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are PRMT5 inhibitors. This patent outlines methods of making compounds of Formula I, pharmaceutical compositions comprising these compounds, and methods of using them to treat cancer, sickle cell disease, and hereditary persistence of fetal hemoglobin (HPFH) mutations.
Career Highlights
Chunghui Huang is currently employed at Merck Sharp & Dohme LLC, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new therapeutic options that can improve patient outcomes.
Collaborations
Some of his notable coworkers include Michelle Machacek and Michael D Altman, who collaborate with him on various research projects and innovations.
Conclusion
Chunghui Huang's work in developing PRMT5 inhibitors represents a significant advancement in the treatment of serious genetic conditions. His contributions to the pharmaceutical field highlight the importance of innovation in improving healthcare solutions.